Efficiency of a drug based on enzymatic protein hydrolysate for parenteral use in complex therapy in dogs and cats

This This paper presents the results of a study of the efficacy of a preparation based on enzymatic protein hydrolysate for parenteral use in combination therapy in dogs and cats, including canine parvovirus enteritis, canine piroplasmosis, protein-losing enteropathy in dogs, and calicivirus infection in cats. In groups of animals that were given the drug «Hydropeptone Plus» in addition to the standard treatment regimen, a more rapid stabilization of the condition was noted, including an increase in body weight and normalization of general and biochemical blood test parameters.presents the results of a study of the efficacy of a preparation based on enzymatic protein hydrolysate for parenteral use in combination therapy in dogs and cats, including canine parvovirus enteritis, canine piroplasmosis, protein-losing enteropathy in dogs, and calicivirus infection in cats. In groups of animals that were given the drug "Hydropeptone® plus" in addition to the standard treatment regimen, a more rapid stabilization of the condition was noted, including an increase in body weight and normalization of general and biochemical blood test parameters.